Cargando…

Practical Issues in the Management of Polycystic Kidney Disease: Blood Pressure and Water Balance

Autosomal dominant polycystic kidney disease is the most common hereditary renal disease affecting more than 13 million people worldwide. Renal function deteriorates as the cysts in both kidneys increase in number and size, which eventually results in end-stage kidney failure. Until recently, conser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hayne Cho, Oh, Yun Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Electrolyte Metabolism 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685325/ https://www.ncbi.nlm.nih.gov/pubmed/36451711 http://dx.doi.org/10.5049/EBP.2022.20.1.10

Ejemplares similares

Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients
por: Oh, Yun Kyu, et al.
Publicado: (2021)

Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Kim, Yaerim, et al.
Publicado: (2023)

Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease
por: Kim, Hyunho, et al.
Publicado: (2019)

Bioelectrical impedance analysis as a nutritional assessment tool in Autosomal Dominant Polycystic Kidney Disease
por: Ryu, Hyunjin, et al.
Publicado: (2019)

Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2019)

Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease
por: Ryu, Hyunjin, et al.
Publicado: (2017)

Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
por: Park, Hayne Cho, et al.
Publicado: (2020)

Author Correction: Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing
por: Kim, Hyunsuk, et al.
Publicado: (2020)

Transcatheter Arterial Embolization Therapy for a Massive Polycystic Liver in Autosomal Dominant Polycystic Kidney Disease Patients
por: Park, Hayne Cho, et al.
Publicado: (2009)

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2015)

Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Han, Miyeun, et al.
Publicado: (2014)

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study
por: Park, Hayne Cho, et al.
Publicado: (2022)

Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume Was Reduced by Rigorous Blood Pressure Control
por: Suwabe, Tatsuya, et al.
Publicado: (2021)

Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
por: Park, Hayne Cho, et al.
Publicado: (2012)

Successfully Treated Escherichia coli-Induced Emphysematous Cyst Infection with Combination of Intravenous Antibiotics and Intracystic Antibiotics Irrigation in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2013)

Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease
por: Choi, Rihwa, et al.
Publicado: (2014)

Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function
por: Huh, Hyuk, et al.
Publicado: (2017)

Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease
por: Hwang, Jin Ho, et al.
Publicado: (2013)

Discrepancies in Clinic and Ambulatory Blood Pressure in Korean Chronic Kidney Disease Patients
por: Oh, Yun Kyu, et al.
Publicado: (2017)

RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study
por: Ryu, Hyunjin, et al.
Publicado: (2020)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022)

Autophagy induction promotes renal cyst growth in polycystic kidney disease
por: Lee, Eun Ji, et al.
Publicado: (2020)

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
por: Huh, Hyuk, et al.
Publicado: (2023)

Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients
por: Park, Hayne Cho, et al.
Publicado: (2015)

Association of Circulating Osteoprotegerin Level with Blood Pressure Variability in Patients with Chronic Kidney Disease
por: Suh, Sang Heon, et al.
Publicado: (2021)

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression
por: Kim, Hyunsuk, et al.
Publicado: (2022)

Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan
por: Müller, Roman-Ulrich, et al.
Publicado: (2018)

Patient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey
por: El-Damanawi, Ragada, et al.
Publicado: (2017)

Moderate–Vigorous Physical Activity and Clinical Outcomes in Adults with Nondialysis Chronic Kidney Disease
por: Kim, Ji Hye, et al.
Publicado: (2021)

Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease
por: Prejbisz, Aleksander, et al.
Publicado: (2013)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Polycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney
por: Chae, Seoung Wan, et al.
Publicado: (2006)

Comprehensive Medication Management as a Standard of Practice for Managing Uncontrolled Blood Pressure
por: Kuo, Tony, et al.
Publicado: (2021)

Clinical significance of central systolic blood pressure in LV diastolic dysfunction and CV mortality
por: Choi, Sun Ryoung, et al.
Publicado: (2021)

Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
por: Brosnahan, Godela M., et al.
Publicado: (2018)

Morning blood pressure surge in early autosomal dominant polycystic kidney disease and its relation with left ventricular hypertrophy
por: Yildiz, Abdülmecit, et al.
Publicado: (2021)

Esophageal Artery Pseudoaneurysm and Takayasu Arteritis in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Kim, Hyunsuk, et al.
Publicado: (2018)

Trends in the Management and Outcomes of Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease
por: Patel, Madhukar S., et al.
Publicado: (2014)

Association of ambulatory blood pressure monitoring with renal outcome in patients with chronic kidney disease
por: Son, Hyung Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v8a0s05ep6e5jbqbt97topjmco